|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 9/12 | (2006.01) |
| A61P 9/12 | (2018.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 9/2009 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/505 | (2013.01) | ||
| A61K 9/2077 | (2013.01) |
| (11) | Number of the document | 3090744 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14876904.5 |
| Date of filing the European patent application | 2014-12-23 | |
| (97) | Date of publication of the European application | 2016-11-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2014/012677 |
| Date | 2014-12-23 |
| (87) | Number | WO 2015/102282 |
| Date | 2015-07-09 |
| (30) | Number | Date | Country code |
| 20130167406 | 2013-12-30 | KR |
| (72) |
LEE, Jae Won , KR
PARK, Cheol Won , KR
JUN, Hun , KR
LEE, Tae Won , KR
KIM, Nam Hyuck , KR
LEE, Sun Young , KR
YU, Ji Hyuck , KR
|
| (73) |
Alvogen Korea Co., Ltd. ,
13 Fl., 10, Gukjegeumyung-ro
Yeongdeungpo-gu, Seoul 07326,
KR
|
| (54) | PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR |
| PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR |